Dräger Medical generates revenues of over €1 billion for the first time

17 May 2005

Lübeck, Germany. Based on Drägerwerk AG’s annual results
released at its annual accounts press conference on April 28, 2005 in
Lübeck, the results of the subgroup Dräger Medical AG & Co. KGaA are
as follows:

Dräger Medical 2004


net of currency effects
€1,023.4 million €920.2 million 11.2%
EBIT €94.2 million €85.3 million 10.4%
EBIT margin 9.2% 9.3%  
ROCE 16.7% 17.8%  
Headcount as of Dec. 31 5,859 5,596 4.7%

According to Dr. Wolfgang Reim, CEO of Dräger Medical AG & Co. KGaA,
the subgroup’s successive growth is attributable to the consistent efforts it has made to globalize operations and bolster its international presence.

This success story is also rooted in the constant pace of restructuring
measures, which has allowed Dräger Medical to develop into a process-oriented global player. Key success factors include innovative products and services as well as the expansion of the sales and service network and the extension of the product range by way of acquisitions.

The ever growing significance of foreign business is reflected in fiscal year 2004 by the fact that 85 percent of all equipment orders were generated outside of Germany (2003: 81 percent). The innovative strength of the subgroup was confirmed in fiscal year 2004 by 30 new patent applications, including a utility model, which were made in the name of Dräger Medical AG & Co. KGaA. In addition, 28 new patents were submitted to foreign patent offices, and international trademark
applications were made for 12 new products.

At €79.5 million, i.e. 7.8 percent of revenues, research and development expenses showed an 18 percent increase year on year (2003: €67.0 million = 7.3 percent), thus highlighting the subgroup’s focus on the future.

Source: Draeger Medical

To top


To top